Half Your SSVI Score Is One Number. Here's What's Actually In It.

CMS has reduced every hospice in the country to a single number between 0 and 16. It is called the Service and Spending Variation Index and it sits in a public file next to your hospice's name, and it is easy to read as a verdict. Before you treat it as one, it helps to know what the number is made of. Half of it is a single measure and that measure is not what it looks like.

Half the score is one number

The SSVI has two halves. Eight of its sixteen points come from utilization measures: the level-of-care mix, the live discharge patterns, and the visits near the end of life. The other eight come from one thing, non-hospice spending, which is the Medicare money spent on your patients outside the hospice benefit.

That spending half is scored on absolute total dollars: not dollars per patient day, not dollars per beneficiary, and not adjusted for how many patients you serve or how sick they are. It is the raw total.

The result is a score that rises with size on its own. CMS sorts that raw total into eight bands, and the top one begins at $538,406 of non-hospice spending in a year. A hospice with a large patient volume clears that line for reasons that have nothing to do with how it runs its care, so 59% of the highest-volume hospices land at a 7 or 8 on the spending half, against 5% of the smallest.

The public file makes this hard to even see, because CMS reports hospice size only in four coarse categories, and the largest is uncapped: everything above roughly 25,000 hospice days a year, about 68 average daily census, is grouped together. A 70-census hospice and one at 1,100 share the same row, indistinguishable in the data. That one open-ended category already carries a median spending score of 7 and a median total SSVI of 8, against a median total of 5 for the smallest hospices. Size bends the spending half well before a hospice is genuinely large, and past that line the data stops showing size at all.

Some of the score is close to automatic

A second thing the number hides is how many of its measures flag a hospice by design.

The most-tripped measure in the entire index is providing no continuous home care and no general inpatient care in a year. Nearly half of all hospices, about 45%, are flagged on it. For a small or facility-based hospice that never had a patient who needed either level of care, it is close to automatic.

Most of the utilization measures work the same way. Six of the eight flag whichever hospices fall in the worst quartile on that measure. Since a quarter of hospices fall in the worst quartile by definition, each of those measures flags about a quarter of the field every year, no matter how anyone actually performed. A flag there tells you where you ranked, not that you did something wrong.

And it moves

The number is also less stable than a single figure suggests. Between FY2024 and FY2025, with no change in methodology, 18% of hospices moved three or more points on a sixteen-point scale. The change split three ways almost evenly, with a bit more than a third rising, a third falling, and the rest unchanged. A single year is a snapshot, not a trend.

Most hospices land in a fairly narrow band. The median total SSVI is 6, and about 65% fall between 4 and 9. Only four hospices in the country scored a 0, and none scored a 16. A 6 or a 7, the number that might look alarming next to your name, is the middle of the pack.

What the number is actually pointing at

None of this makes the SSVI meaningless. Once you set aside the part that is size, the part that is automatic, and the part that is noise, there is a real signal left and it lives inside the spending dollars.

Non-hospice spending rises when care that should have been the hospice's responsibility gets billed somewhere else. Some of that spending is genuinely unrelated to the terminal illness and belongs outside the benefit. Some of it is a relatedness determination that was never made cleanly, or a coverage question that got answered at a pharmacy counter instead of by the hospice. That is the part a hospice can actually act on, and it is not "spend less." It is knowing what you cover and why, and making sure that decision reaches the places that bill for it.

This is where MerlinRx works. Not on the score, which is a consequence, but on the relatedness and coverage decisions underneath it, surfaced where the care team makes them, so the spending outside the benefit reflects deliberate calls rather than gaps. The work is getting those determinations right, and the number is only ever a reflection of them.

Read the number for what it is

The SSVI is a starting question, not a report card. The part worth your attention is small: the handful of coverage and relatedness decisions behind the dollars, which is the part the number is least equipped to show you.

That gap between what the score measures and what actually drives it is what we dig into in a live session.

On September 23rd, we are taking apart the SSVI, the relaunched PEPPER report, and the new Non-Covered Items Addendum, showing how all three converge on the same handful of decisions.

Register at merlinrx.info/webinar.